The frequency of vitamin D deficiency in chronic kidney disease and its relation with baseline mineral bone markers.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as an observational study.

To assess the frequency of Vitamin D deficiency in chronic kidney disease and its association with baseline mineral bone markers in patients visiting nephrology clinics.

Who Took Part

The study group was 2018, patients.

The age groups tagged for this paper are adults, both men and women.

The observational study was conducted at the Indus Hospital, Karachi, from January 2017 to January 2018, and comprised patients of either gender aged >16 years diagnosed with chronic kidney disease stage I-V.

The patients were divided into two groups on the basis of severity of vitamin D deficiency.

How the Study Was Run

Severe vitamin D deficiency was defined as <10ng/ml, and moderate deficiency ad 10- 25ng/ml.

Data was analysed using SPSS 21.

What Was Measured

Topics PubMed links to this paper include Age Factors, Bone Density, Correlation of Data, Employment, Pakistan, Renal Insufficiency, Chronic and Risk Factors.

The authors tagged it with the keywords CKD, Vitamin D deficiency, Mineral bone markers.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc in 2018, patients.

With several hundred people or more, it is a fairly large study for this kind of research.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2020 (JPMA. The Journal of the Pakistan Medical Association), a journal based in Pakistan.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.